TNSN99133A1 - Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus - Google Patents
Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenusInfo
- Publication number
- TNSN99133A1 TNSN99133A1 TNTNSN99133A TNSN99133A TNSN99133A1 TN SN99133 A1 TNSN99133 A1 TN SN99133A1 TN TNSN99133 A TNTNSN99133 A TN TNSN99133A TN SN99133 A TNSN99133 A TN SN99133A TN SN99133 A1 TNSN99133 A1 TN SN99133A1
- Authority
- TN
- Tunisia
- Prior art keywords
- products
- preparation
- schiff bases
- improved process
- schiff
- Prior art date
Links
- 239000002262 Schiff base Substances 0.000 title abstract 2
- 150000004753 Schiff bases Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
-L'INVENTION CONCERNE UN PROCEDE POUR LA PREPARATION DE PRODUITS FINALS D'ADDITION PAR CONDENSATION CONSISTANT EN BASES DE SCHIFF. LES CONSTITUANTS DE CES PRODUITS COMPRENNENT UNE PROTEINE A ACTIVITE BENEFIQUE CHEZ DES ANIMAUX ET UN O-HYDROXY-ALDEHYDE AROMATIQUE. ELLE CONCERNE EGALEMENT LES BASES DE SCHIFF AINSI OBTENUES. APPLICATION : UTILISATION DES PRODUITS OBTENUS POUR LE TRAITEMENT D'ANIMAUX ET DE L'HOMME.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9071498P | 1998-06-26 | 1998-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN99133A1 true TNSN99133A1 (fr) | 2005-11-10 |
Family
ID=22223965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN99133A TNSN99133A1 (fr) | 1998-06-26 | 1999-06-23 | Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus |
Country Status (23)
Country | Link |
---|---|
US (1) | US20030125528A1 (fr) |
EP (1) | EP1087989A1 (fr) |
JP (1) | JP2002519356A (fr) |
KR (1) | KR20010083070A (fr) |
CN (1) | CN1305490A (fr) |
AP (1) | AP9901593A0 (fr) |
AU (1) | AU3842499A (fr) |
BR (1) | BR9912203A (fr) |
CA (1) | CA2331388A1 (fr) |
CZ (1) | CZ20004806A3 (fr) |
GT (1) | GT199900097A (fr) |
HU (1) | HUP0102693A3 (fr) |
ID (1) | ID27131A (fr) |
IL (1) | IL139585A0 (fr) |
MA (1) | MA24885A1 (fr) |
PA (1) | PA8476501A1 (fr) |
PL (1) | PL345264A1 (fr) |
RU (1) | RU2201936C2 (fr) |
TN (1) | TNSN99133A1 (fr) |
TR (1) | TR200003732T2 (fr) |
UY (1) | UY25579A1 (fr) |
WO (1) | WO2000000507A1 (fr) |
YU (1) | YU78600A (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1136080A3 (fr) * | 2000-03-14 | 2002-06-05 | Pfizer Products Inc. | Utilisation d'O-vanilline et de combinaisons O-Vanilline/Trolox |
US20050142217A1 (en) * | 2000-04-26 | 2005-06-30 | Adams Michael A. | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
US6432077B1 (en) * | 2000-12-26 | 2002-08-13 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
KR101058467B1 (ko) | 2004-10-27 | 2011-08-24 | 유니버시티 오브 덴버 | 부신피질 자극 호르몬 유사체 및 관련 방법 |
ITMO20060222A1 (it) * | 2006-07-10 | 2008-01-11 | Alfio Bertolini | Pacchetto di medicazione antiemorragico |
CN103450077B (zh) * | 2007-06-08 | 2016-07-06 | 满康德股份有限公司 | IRE-1α抑制剂 |
JP2011504477A (ja) * | 2007-11-22 | 2011-02-10 | ノボ ノルディスク ヘルス ケア アーゲー | アルデヒド含有化合物による液体製剤化第VII(a)因子ポリペプチドの安定化 |
MX348705B (es) | 2008-09-17 | 2017-06-26 | Chiasma Inc | Composiciones farmacéuticas y métodos de administración relacionados. |
WO2012074860A1 (fr) * | 2010-12-03 | 2012-06-07 | Dow Agrosciences Llc | Procédés de préparation d'énamines |
CN104262600B (zh) * | 2014-09-09 | 2016-01-06 | 天津大学 | 同一侧基上含有西弗碱和巯基的双重敏感型两亲性共聚物及其制备方法与应用 |
WO2016057754A1 (fr) * | 2014-10-10 | 2016-04-14 | The University Of Kansas | Activité antibiotique de polymères séquestrant le fer |
WO2016126830A1 (fr) | 2015-02-03 | 2016-08-11 | Chiasma Inc. | Méthode de traitement de maladies |
WO2017180714A1 (fr) * | 2016-04-12 | 2017-10-19 | University Of Kansas | Activité antifongique de polymères séquestrant le fer |
CN106008566A (zh) * | 2016-06-27 | 2016-10-12 | 金子烁 | 5-氯水杨醛缩丙氨酸席夫碱锌配合物及其制备方法 |
RU2729391C2 (ru) * | 2018-12-28 | 2020-08-06 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Моноклональное антитело, способное нейтрализовать биологическую активность интерферона бета-1а человека |
CN110332260B (zh) * | 2019-08-12 | 2021-09-24 | 湖北康晨安宝矿业设备有限责任公司 | 一种前桥行驻一体制动器 |
CN112194574B (zh) * | 2020-10-13 | 2022-03-29 | 天津大学 | 一种邻香草醛球形晶体的制备方法 |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
CN113105359A (zh) * | 2021-03-05 | 2021-07-13 | 天津大学 | 一种席夫碱化合物及其制备方法 |
CN115053909B (zh) * | 2022-06-22 | 2024-04-19 | 湖南工业大学 | 一种生物基绿色复合抗菌剂及其制备方法和应用 |
CN116173314B (zh) * | 2023-01-17 | 2024-04-16 | 成都美益博雅材料科技有限公司 | 复合材料及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8703718D0 (en) * | 1987-02-18 | 1987-03-25 | Dalgety Uk Ltd | Colour production |
DE68924783T2 (de) * | 1988-09-30 | 1996-03-28 | Neorx Corp | Wässrige additivsysteme, verfahren und polymerteilchen. |
US5198422A (en) * | 1992-06-11 | 1993-03-30 | Smithkline Beecham Corporation | Stabilized somatotropin for parenteral administration |
-
1999
- 1999-06-02 AU AU38424/99A patent/AU3842499A/en not_active Abandoned
- 1999-06-02 EP EP99921066A patent/EP1087989A1/fr not_active Withdrawn
- 1999-06-02 JP JP2000557268A patent/JP2002519356A/ja active Pending
- 1999-06-02 BR BR9912203-0A patent/BR9912203A/pt not_active IP Right Cessation
- 1999-06-02 ID IDW20002725A patent/ID27131A/id unknown
- 1999-06-02 HU HU0102693A patent/HUP0102693A3/hu unknown
- 1999-06-02 WO PCT/IB1999/000993 patent/WO2000000507A1/fr not_active Application Discontinuation
- 1999-06-02 PL PL99345264A patent/PL345264A1/xx not_active Application Discontinuation
- 1999-06-02 RU RU2000133344/04A patent/RU2201936C2/ru not_active IP Right Cessation
- 1999-06-02 CZ CZ20004806A patent/CZ20004806A3/cs unknown
- 1999-06-02 CN CN99807518A patent/CN1305490A/zh active Pending
- 1999-06-02 IL IL13958599A patent/IL139585A0/xx unknown
- 1999-06-02 YU YU78600A patent/YU78600A/sh unknown
- 1999-06-02 KR KR1020007014840A patent/KR20010083070A/ko active IP Right Grant
- 1999-06-02 TR TR2000/03732T patent/TR200003732T2/xx unknown
- 1999-06-02 CA CA002331388A patent/CA2331388A1/fr not_active Abandoned
- 1999-06-22 UY UY25579A patent/UY25579A1/es not_active Application Discontinuation
- 1999-06-23 MA MA25643A patent/MA24885A1/fr unknown
- 1999-06-23 TN TNTNSN99133A patent/TNSN99133A1/fr unknown
- 1999-06-24 GT GT199900097A patent/GT199900097A/es unknown
- 1999-06-24 AP APAP/P/1999/001593A patent/AP9901593A0/en unknown
- 1999-06-25 PA PA19998476501A patent/PA8476501A1/es unknown
-
2002
- 2002-09-27 US US10/256,482 patent/US20030125528A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MA24885A1 (fr) | 1999-12-31 |
ID27131A (id) | 2001-03-01 |
PA8476501A1 (es) | 2001-12-14 |
US20030125528A1 (en) | 2003-07-03 |
CA2331388A1 (fr) | 2000-01-06 |
PL345264A1 (en) | 2001-12-03 |
YU78600A (sh) | 2002-11-15 |
CZ20004806A3 (cs) | 2001-08-15 |
KR20010083070A (ko) | 2001-08-31 |
BR9912203A (pt) | 2001-04-10 |
IL139585A0 (en) | 2002-02-10 |
EP1087989A1 (fr) | 2001-04-04 |
CN1305490A (zh) | 2001-07-25 |
GT199900097A (es) | 2000-12-15 |
AU3842499A (en) | 2000-01-17 |
TR200003732T2 (tr) | 2001-06-21 |
HUP0102693A2 (hu) | 2001-11-28 |
RU2201936C2 (ru) | 2003-04-10 |
HUP0102693A3 (en) | 2002-12-28 |
WO2000000507A1 (fr) | 2000-01-06 |
AP9901593A0 (en) | 1999-06-30 |
JP2002519356A (ja) | 2002-07-02 |
UY25579A1 (es) | 2000-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN99133A1 (fr) | Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus | |
TNSN98019A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
ATE500823T1 (de) | Arzneimittel zur behandlung von hiv-infizierten säugetieren | |
EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
TNSN98025A1 (fr) | Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant. | |
AU2001272735A1 (en) | Novel physiologically active peptide and use thereof | |
TNSN98059A1 (fr) | Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant. | |
TNSN97078A1 (fr) | Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant | |
TNSN99106A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
HU229448B1 (en) | Multicyclic compounds and pharmaceutical compositions containing them | |
MA26420A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation. | |
CA2330500A1 (fr) | Compositions pharmaceutiques gelifiables | |
DZ3165A1 (fr) | Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie. | |
FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
FR2755136B1 (fr) | Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant | |
BR0312456A (pt) | Anticorpo alterado ou fragmento funcional do mesmo, polinucleotìdeo, sequência de polinucleotìdeo, composição farmacêutica, métodos de tratamento ou profilaxia de derrame e outras doenças/distúrbios neurológicos em um ser humano, de inibição da neurodegeneração e/ou promoção da recuperação funcional e de promoção do desenvolvimento axonial, e, uso de um anticorpo anti-mag | |
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
PL308142A1 (en) | Derivatives of 2-amino-4phenyl-4-oxobutyric acids as kynureninase and/or kynurenic 3-hydroxylase inhibitors | |
ES2002398A6 (es) | Procedimiento para preparar nuevas enolamidas | |
ATE409028T1 (de) | Arzneien zur behandlung von nervenerkrankungen | |
ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
TNSN98124A1 (fr) | Compositions de sertraline solubilisee | |
ATE249837T1 (de) | Caspase 8-inhibitoren zur immunsuppression | |
TR199902564T2 (xx) | K�k�rdak oligomer matris proteininin romatoid artrit tedavisinde kullan�m�. | |
WO1999050671A3 (fr) | Proteine toso comme cible de criblage de medicaments |